✦ LIBER ✦

A statistical framework for differential network analysis from microarray data

✍ Scribed by Ryan Gill; Somnath Datta; Susmita Datta

Book ID: 114999375
Publisher: BioMed Central
Year: 2010
Tongue: English
Weight: 568 KB
Volume: 11
Category: Article
ISSN: 1471-2105
DOI: 10.1186/1471-2105-11-95

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A probabilistic framework for microarray

A probabilistic framework for microarray data analysis: Fundamental probability models and statistical inference

✍ Babatunde A. Ogunnaike; Claudio A. Gelmi; Jeremy S. Edwards 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 586 KB

ROOT — A C++ framework for petabyte data

ROOT — A C++ framework for petabyte data storage, statistical analysis and visualization

✍ I. Antcheva; M. Ballintijn; B. Bellenot; M. Biskup; R. Brun; N. Buncic; Ph. Cana 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 96 KB

A benchmark for statistical microarray d

A benchmark for statistical microarray data analysis that preserves actual biological and technical variance

✍ Benoît De Hertogh; Bertrand De Meulder; Fabrice Berger; Michael Pierre; Eric Bar 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 741 KB

Ranking analysis of microarray data: A p

Ranking analysis of microarray data: A powerful method for identifying differentially expressed genes

✍ Yuan-De Tan; Myriam Fornage; Yun-Xin Fu 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 588 KB

ExpressionPlot: a web-based framework fo

ExpressionPlot: a web-based framework for analysis of RNA-Seq and microarray gene expression data

✍ Brad A Friedman; Tom Maniatis 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 916 KB

A framework for cost-effectiveness analy

A framework for cost-effectiveness analysis from clinical trial data

✍ Anthony O'Hagan; John W. Stevens 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 262 KB 👁 1 views

## Abstract We present a general Bayesian framework for cost‐effectiveness analysis (CEA) from clinical trial data. This framework allows for very flexible modelling of both cost and efficacy related trial data. A common CEA technique is established for this wide class of models through linking mea